Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Anthony @ Equity Investigations, Dear Anthony, -- Ignore unavailable to you. Want to Upgrade?

To: Doorman who wrote (21082)	3/16/1999 11:28:00 AM
From: M. LaMancha	Read Replies (1) \| Respond to of 122087

ENMD -- your point about the years of testing needed is on the mark. But I really don't believe this stuff will ever get injected into humans. Dr. Folkman has been working on this for 15 years or so. It's literally a pioneering anti-angiogenesis agent. Others have come along since. IMO only, of course, amount of effort that had to be done just to replicate the Boston work -- the NCI people had to go to Folkman's lab because they couldn't get the same results in their own, and NCI has the best equipment you're going to find -- says it all. Clinical trials will likely fail if mouse trials can't be easily replicated. (I say likely because nothing is for sure) But I jsut can't see it working in people -- ever.